ClinicalTrials.gg
RecruitingNCT07539103VIRAGEUpdated Nov 6, 2026

VIRal Pulmonary Infections in Older AGE

An observational study in Viral Pulmonary Infections, sponsored by Gérond'if. Recruiting at 20 sites in France. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Gérond'if · Observational

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Nov 6, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
5,900
Ages
60 Years and older
Sex
All
01

Study summary

Severe acute respiratory infections (SARIs) represent one of the leading causes of hospitalization and mortality worldwide. These infections are associated with substantial in-hospital mortality and often constitute a turning point in the medium-term prognosis of older patients and those with comorbid conditions.

SARIs are most frequently of viral origin, involving well-known pathogens such as Orthomyxoviridae (influenza A and B viruses), Pneumoviridae [(respiratory syncytial virus (RSV), human metapneumovirus (hMPV)], Paramyxoviridae [parainfluenza viruses (PIV)], adenoviruses, or rhinoviruses, as well as emerging viruses such as pandemic influenza strains and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic.

Age-related immune decline (immunosenescence) increases the risk of severe forms and related respiratory or cardiovascular complications. However, the prevalence and burden of the different viral etiologies of Severe acute respiratory infections (SARIs) in older adults remain limited and insufficiently characterized.

The primary objective is to determine the proportion of viral respiratory infections attributable to polymerase chain reaction (PCR)-confirmed pathogen agents among hospitalized older subjects (≥60 years old).

Read the detailed description

This is an observational, prospective, multicentre study in hospitalized older patients (≥60 years old) who have undergone viral respiratory sampling (RT-PCR or multiplex RT-PCR).

Subjects will be recruited over a period of 24 months at approximately 20 centres. Each subject will participate in the study for 3 months (Screening/inclusion visit and 3-month follow-up phone calls post hospital discharge). A respiratory sample (nasopharyngeal or nasal swab, oropharyngeal swab, aspirate, or bronchoalveolar lavage fluid) will be collected as part of standard of care and analysed by the local virology laboratory for the detection of respiratory virus(es) responsible for the infection, using validated Reverse transcription polymerase chain reaction (RT-PCR) or multiplex RT-PCR assays.

02

Conditions studied

  • Viral Pulmonary Infections

Keywords

  • PCR
  • viral respiratory infections
  • viral respiratory pathogen
  • polymerase chain reaction
03

In context

Lead sponsor

Gérond'if is the lead sponsor of 35 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Hospitalized older patients (≥60 years old) tested for PCR as part of standard of care (SoC). Subjects meeting the eligibility criteria will be invited to participate in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Hospitalized subjects aged ≥ 60 years
  • A respiratory sample collected and tested by polymerase chain reaction (PCR) during hospitalisation as part of standard of care

Note: Reasons for PCR:

  1. Patients with Severe acute respiratory infection (SARI)
  2. Patients with symptoms other than SARI
  3. Systematic PCR testing (in the context of clusters or during the winter season) * Recent onset of at least one general symptom and at least one functional or physical respiratory sign

    • General symptoms: fever (which may be absent in older patients), chills, sweating, headache, malaise, myalgia, arthralgia, fatigue, decline in general condition (asthenia, weight loss, anorexia, confusion, or dizziness), digestive disturbances.
    • Respiratory signs: sore throat, rhinorrhoea (common cold), cough, wheezing, dyspnoea, chest pain, or recent auscultatory abnormalities (diffuse or focal).
    • Subjects willing to participate, with a non-opposition form completed and signed by the qualified and trained healthcare professional responsible for providing the participant information
    • Subject affiliated to a health insurance system

Exclusion criteria

Exclusion Criteria:

  • Subjects refusing to participate
  • Subjects admitted to palliative care unit.

    • Subjects under guardianship
    • Any condition that, in the opinion of the investigator, may interfere with the aim of the study or wellbeing of the patient
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
5,900 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Number of RT-PCR-confirmed positive cases for viral pathogen agents of interest among hospitalized older subjects (≥60 years old)

    Time frame: At baseline

Secondary outcomes

  1. Number of RT-PCR-confirmed positive cases for each viral pathogen agent of interest among hospitalized older subjects

    Time frame: From baseline to 3-month follow-up

  2. Number of RT-PCR-confirmed positive cases for each viral pathogen of interest among hospitalized older subjects according to the vaccination status

    Time frame: From baseline to 3-month follow-up

  3. Number of RT-PCR -confirmed positive cases for each viral respiratory pathogen of interest among hospitalized older subjects according to the indication of PCR

    Time frame: From baseline to 3-month follow-up

  4. Comparison of the prevalence of viral respiratory pathogen of interest among hospitalized older subjects by age groups

    Time frame: From baseline to 3-month follow-up

  5. Hospital burden of acute respiratory infections

    including: * Mortality (in-hospital and at 3-month follow-up) * Length of hospital stay, admissions to intensive or critical care units, and use of ventilatory support (mechanical ventilation) * In-hospital geriatric syndromes: • Delirium: CAM (Confusion Assessment Method) score • Malnutrition: weight loss, serum albumin • Sarcopenia: one-leg stance test (unipedal stance test), Timed Up and Go (TUG) test (at admission and discharge) • Cognitive impairment: MMSE (Mini-Mental State Examination) score • Pressure ulcers * Extra-respiratory complications (in-hospital and during follow-up): • Cardiovascular complications (acute coronary syndrome, heart failure, atrial fibrillation, stroke) • Non-cardiovascular complications (digestive disorders, non-respiratory infections, acute kidney injury, metabolic disorders, etc.) * Functional autonomy: 15 days before hospitalization, at discharge, and at 3 months using ADL (Activities of Daily Living) and IADL (Instrumental Activities of Daily Living) sc

    Time frame: From baseline to 3 month follow up

  6. Hospital burden of acute viral respiratory infections according to the indication of PCR

    Time frame: From baseline to 3 month follow up

  7. Prevalence of co-infections with the viral respiratory pathogens of interest among hospitalized older subjects.

    Time frame: From baseline to 3-month follow-up

  8. Patient characterization by age, sex, associated protective and risk factors, overall and by viral pathogen.

    Time frame: At baseline

  9. Epidemiological trends and seasonality of respiratory viruses during the study period.

    Time frame: From baseline to 3 month follow up

07

Study locations

5 of 20 sites recruiting
08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Oct 2026 (actual). Primary completion is estimated for Jan 2029, 26 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 28, 2026: start Jun 2026 → Oct 2026, primary completion Sep 2028 → Jan 2029 and completion Sep 2028 → Jan 2029.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 1, 2026
First posted
Apr 20, 2026
StartActual
Oct 22, 2026was Jun 2026
Primary completionEst.
Jan 21, 2029was Sep 2028
CompletionEst.
Jan 21, 2029was Sep 2028
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 28, 2026
Sites
20 sites changed recruiting status (15 now not yet recruiting, 5 now recruiting)
Show 20 sites
  • CHU Bordeaux · Pessac, Franceno status→Not yet recruiting
  • CHU Amiens Picardie · Amiens, Franceno status→Not yet recruiting
  • Centre Hospitalier Départemental Vendée_La Roche sur Yon · La Roche-sur-Yon, Franceno status→Recruiting
  • CHU Nimes · Nîmes, Franceno status→Not yet recruiting
  • Hôpital St Antoine · Paris, Franceno status→Not yet recruiting
  • Hôpital Broca - APHP · Paris, Franceno status→Recruiting
  • Hôpital Avicenne APHP · Bobigny, Franceno status→Recruiting
  • Hôpital Ambroise Paré-APHP · Boulogne-Billancourt, Franceno status→Not yet recruiting
  • Hôpital Henri Mondor APHP · Créteil, Franceno status→Not yet recruiting
  • Hôpital Corentin Celton APHP, Gérontologie 1 · Issy-les-Moulineaux, Franceno status→Not yet recruiting
  • Hôpital Corentin Celton APHP, Gérontologie 2 · Issy-les-Moulineaux, Franceno status→Recruiting
  • Hôpital Charles Foix APHP · Ivry-sur-Seine, Franceno status→Not yet recruiting
  • CH de Versailles · Le Chesnay, Franceno status→Not yet recruiting
  • Hôpital Emile Roux APHP · Limeil-Brévannes, Franceno status→Recruiting
  • HEGP · Paris, Franceno status→Not yet recruiting
  • Hôpital Bretonneau APHP · Paris, Franceno status→Not yet recruiting
  • Hôpital Sainte Périne · Paris, Franceno status→Not yet recruiting
  • Hôpital Lariboisière - APHP · Paris, Franceno status→Not yet recruiting
  • Hôpital Bichat-APHP · Paris, Franceno status→Not yet recruiting
  • Hôpital Paul Brousse APHP · Villejuif, Franceno status→Not yet recruiting
across 2 updates, Oct 28, 2026 – Nov 6, 2026
Start date
Jun 1, 2026→Oct 22, 2026 (actual)
Oct 28, 2026
Primary completion
Sep 30, 2028→Jan 21, 2029
Oct 28, 2026
Study completion
Sep 30, 2028→Jan 21, 2029
Oct 28, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • CHU Amiens Picardie · Amiens, FranceContact added l•••@chu-amiens.fr · •••8813
Oct 28, 2026
Show all 2 updates
  1. Nov 6, 2026
    2 sites changed recruiting status (2 now recruiting)
    Show 2 sites
    • Hôpital Broca - APHP · Paris, FranceNot yet recruiting→Recruiting
    • Hôpital Emile Roux APHP · Limeil-Brévannes, FranceNot yet recruiting→Recruiting
    + 1 other change: verification date
  2. Oct 28, 2026
    Not yet recruiting→Recruiting
    20 sites changed recruiting status (17 now not yet recruiting, 3 now recruiting)
    Show 20 sites
    • CHU Bordeaux · Pessac, Franceno status→Not yet recruiting
    • CHU Amiens Picardie · Amiens, Franceno status→Not yet recruiting
    • Centre Hospitalier Départemental Vendée_La Roche sur Yon · La Roche-sur-Yon, Franceno status→Recruiting
    • CHU Nimes · Nîmes, Franceno status→Not yet recruiting
    • Hôpital St Antoine · Paris, Franceno status→Not yet recruiting
    • Hôpital Broca - APHP · Paris, Franceno status→Not yet recruiting
    • Hôpital Avicenne APHP · Bobigny, Franceno status→Recruiting
    • Hôpital Ambroise Paré-APHP · Boulogne-Billancourt, Franceno status→Not yet recruiting
    • Hôpital Henri Mondor APHP · Créteil, Franceno status→Not yet recruiting
    • Hôpital Corentin Celton APHP, Gérontologie 1 · Issy-les-Moulineaux, Franceno status→Not yet recruiting
    • Hôpital Corentin Celton APHP, Gérontologie 2 · Issy-les-Moulineaux, Franceno status→Recruiting
    • Hôpital Charles Foix APHP · Ivry-sur-Seine, Franceno status→Not yet recruiting
    • CH de Versailles · Le Chesnay, Franceno status→Not yet recruiting
    • Hôpital Emile Roux APHP · Limeil-Brévannes, Franceno status→Not yet recruiting
    • HEGP · Paris, Franceno status→Not yet recruiting
    • Hôpital Bretonneau APHP · Paris, Franceno status→Not yet recruiting
    • Hôpital Sainte Périne · Paris, Franceno status→Not yet recruiting
    • Hôpital Lariboisière - APHP · Paris, Franceno status→Not yet recruiting
    • Hôpital Bichat-APHP · Paris, Franceno status→Not yet recruiting
    • Hôpital Paul Brousse APHP · Villejuif, Franceno status→Not yet recruiting
    Start date Jun 1, 2026→Oct 22, 2026 (now actual)
    Primary completion Sep 30, 2028→Jan 21, 2029
    Study completion Sep 30, 2028→Jan 21, 2029
    Site contacts Changed at 1 site. See the sites
    Show the site
    • CHU Amiens Picardie · Amiens, FranceContact added l•••@chu-amiens.fr · •••8813
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07539103
Lead sponsor
Gérond'if
Responsible party
Sponsor
First posted
Apr 20, 2026
Start date
Oct 22, 2026
Primary completion
Jan 21, 2029 (estimated)
Completion
Jan 21, 2029 (estimated)
Last update
Nov 6, 2026

Study contacts

Isabelle Dufour
Contact
isabelle.dufour@gerondif.org
+33 (0) 185781011
Prisca Lucas, PhD MPH
Contact
prisca.lucas@gerondif.org
+33 (0)185737323
Olivier Hanon, MD PhD
study chair · Geriatric Department, Broca hospital
LAUNAY Odile, MD PhD
study chair · CIC de Vaccinologie Cochin Pasteur (CIC 1417)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion